These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31253832)

  • 1. Label propagation defines signaling networks associated with recurrently mutated cancer genes.
    Cakir M; Mukherjee S; Wood KC
    Sci Rep; 2019 Jun; 9(1):9401. PubMed ID: 31253832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer systems biology: exploring cancer-associated genes on cellular networks.
    Wang E; Lenferink A; O'Connor-McCourt M
    Cell Mol Life Sci; 2007 Jul; 64(14):1752-62. PubMed ID: 17415519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways in tumor progression: from discovery to functional understanding.
    Ali MA; Sjöblom T
    Mol Biosyst; 2009 Sep; 5(9):902-8. PubMed ID: 19668850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes.
    Liu C; Zhao J; Lu W; Dai Y; Hockings J; Zhou Y; Nussinov R; Eng C; Cheng F
    PLoS Comput Biol; 2020 Feb; 16(2):e1007701. PubMed ID: 32101536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks.
    Hodzic E; Shrestha R; Zhu K; Cheng K; Collins CC; Cenk Sahinalp S
    Gigascience; 2019 Apr; 8(4):. PubMed ID: 30978274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative pathway enrichment analysis of multivariate omics data.
    Paczkowska M; Barenboim J; Sintupisut N; Fox NS; Zhu H; Abd-Rabbo D; Mee MW; Boutros PC; ; Reimand J;
    Nat Commun; 2020 Feb; 11(1):735. PubMed ID: 32024846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
    Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
    BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation patterns in signaling networks of cancer.
    Schramm G; Kannabiran N; König R
    BMC Syst Biol; 2010 Nov; 4():162. PubMed ID: 21110851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
    Fleck JL; Pavel AB; Cassandras CG
    BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.
    Ruffalo M; Koyutürk M; Sharan R
    PLoS Comput Biol; 2015 Dec; 11(12):e1004595. PubMed ID: 26683094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
    Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D
    Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic data integration in chronic lymphocytic leukemia.
    Fernández-Martínez JL; deAndrés-Galiana EJ; Sonis ST
    J Gene Med; 2017 Jan; 19(1-2):. PubMed ID: 27928896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network-Based Coverage of Mutational Profiles Reveals Cancer Genes.
    Hristov BH; Singh M
    Cell Syst; 2017 Sep; 5(3):221-229.e4. PubMed ID: 28957656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.